High expression of ubiquitin conjugates and NF-κB in unstable human intracranial atherosclerotic plaques

Journal of Cellular Physiology

Volumn 227, Issue 2, 2012, Pages 784-788

  Sun, Ruihong ^a   Xiao, Ling ^a   Duan, Shurong ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UBIQUITIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; BRAIN ATHEROSCLEROSIS; BRAIN INFARCTION; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGED; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; MALE; MIDDLE AGED; NF-KAPPA B; PLAQUE, ATHEROSCLEROTIC; POLYMERS; STAINING AND LABELING; UBIQUITIN;

EID: 82155163842     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22790     Document Type: Article

References (28)

1. Bae HJ, Yoon BW, Kang DW, Koo JS, Lee SH, Kim KB, Lee J, Roh JK. 2006. Correlation of coronary and cerebral atherosclerosis: Difference between extracranial and intracranial arteries. Cerebrovasc Dis 21: 112-119.
2. Benagiano M, Azzurri A, Ciervo A, Amedei A, Tamburini C, Ferrari M, Telford H, Baldari CT, Romagnani S, Cassone A, Del Prete G. 2003. T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions. Proc Natl Acad Sci USA 100: 6658-6663.
3. Bulteau AL, Lundberg KC, Humphries KM, Sadek HA, Szweda PA, Friguet B, Szweda LI. 2001. Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J Biol Chem 276: 30057-30063.
4. Chang HJ, Yoon G, Park JS, Kim MH, Baek MK, Kim NH, Shin BA, Ahn BW, Cheon SH, Jung YD. 2007. Induction of apoptosis by the licochalcone E in endothelial cells via modulation of NF-kappaB and Bcl-2 Family. Biol Pharm Bull 30: 2290-2293.
5. de Winther MP, Kanters E, Kraal G, Hofker MH. 2005. Nuclear factor kappaB signaling in atherogenesis. Arterioscler Thromb Vasc Biol 25: 904-914.
6. Di Filippo C, Marfella R, D'Amico M. 2008. Possible dual role of ubiquitin-proteasome system in the atherosclerotic plaque progression. J Am Coll Cardiol 52: 1350-1351.
7. Donaldson KM, Li W, Ching KA, Batalov S, Tsai CC, Joazeiro CA. 2003. Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates. Proc Natl Acad Sci USA 100: 8892-8897.
8. Galis ZS, Sukhova GK, Lark MW, Libby P. 1994. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94: 2493-2503.
9. Gareus R, Kotsaki E, Xanthoulea S, van der Made I, Gijbels MJ, Kardakaris R, Polykratis A, Kollias G, de Winther MP, Pasparakis M. 2008. Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis. Cell Metab 8: 372-383.
10. Golledge J, Greenhalgh RM, Davies AH. 2000. The symptomatic carotid plaque. Stroke 31: 774-781.
11. Hajra L, Evans AI, Chen M, Hyduk SJ, Collins T, Cybulsky MI. 2000. The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. Proc Natl Acad Sci USA 97: 9052-9057.
12. Hansson GK. 2001. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 21: 1876-1890.
13. Hermann J, Gulati R, Napoli C, Woodrum JE, Lerman LO, Rodriguez-Porcel M, Sica V, Simari RD, Ciechanover A, Lerman A. 2003. Oxidative stress-related increase in ubiquitination in early coronary atherogenesis. FASEB J 17: 1730-1732.
14. Herrmann J, Edwards WD, Holmes DR, Jr., Shogren KL, Lerman LO, Ciechanover A, Lerman A. 2002. Increased ubiquitin immunoreactivity in unstable atherosclerotic plaques associated with acute coronary syndromes. J Am Coll Cardiol 40: 1919-1927.
15. Herrmann J, Soares SM, Lerman LO, Lerman A. 2008. Potential role of the ubiquitin-proteasome system in atherosclerosis: Aspects of a protein quality disease. J Am Coll Cardiol 51: 2003-2010.
16. Herrmann J, Lerman LO, Lerman A. 2010. On to the road to degradation: Atherosclerosis and the proteasome. Cardiovasc Res 85: 291-302.
17. Li Q, Verma IM. 2002. NF-kappaB regulation in the immune system. Nat Rev Immunol 2: 725-734.
18. Marfella R, D'Amico M, Di Filippo C, Baldi A, Siniscalchi M, Sasso FC, Portoghese M, Carbonara O, Crescenzi B, Sangiuolo P, Nicoletti GF, Rossiello R, Ferraraccio F, Cacciapuoti F, Verza M, Coppola L, Rossi F, Paolisso G. 2006a. Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: Effects of rosiglitazone treatment. J Am Coll Cardiol 47: 2444-2455.
19. Marfella R, D'Amico M, Esposito K, Baldi A, Di Filippo C, Siniscalchi M, Sasso FC, Portoghese M, Cirillo F, Cacciapuoti F, Carbonara O, Crescenzi B, Baldi F, Ceriello A, Nicoletti GF, D'Andrea F, Verza M, Coppola L, Rossi F, Giugliano D. 2006b. The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: Effects of rosiglitazone treatment. Diabetes 55: 622-632.
20. Marfella R, D' Amico M, Di Filippo C, Siniscalchi M, Sasso FC, Ferraraccio F, Rossi F, Paolisso G. 2007a. The possible role of the ubiquitin proteasome system in the development of atherosclerosis in diabetes. Cardiovasc Diabetol 6: 35.
21. Marfella R, Siniscalchi M, Portoghese M, Di Filippo C, Ferraraccio F, Schiattarella C, Crescenzi B, Sangiuolo P, Ferraro G, Siciliano S, Cinone F, Mazzarella G, Martis S, Verza M, Coppola L, Rossi F, D'Amico M, Paolisso G. 2007b. Morning blood pressure surge as a destabilizing factor of atherosclerotic plaque: Role of ubiquitin-proteasome activity. Hypertension 49: 784-791.
22. Mazighi M, Labreuche J, Gongora-Rivera F, Duyckaerts C, Hauw JJ, Amarenco P. 2008. Autopsy prevalence of intracranial atherosclerosis in patients with fatal stroke. Stroke 39: 1142-1147.
23. Nichols TC, Fischer TH, Deliargyris EN, Baldwin AS, Jr. 2001. Role of nuclear factor-kappa B (NF-kappa B) in inflammation, periodontitis, and atherogenesis. Ann Periodontol 6: 20-29.
24. Uehara T, Tabuchi M, Hayashi T, Kurogane H, Yamadori A. 1996. Asymptomatic occlusive lesions of carotid and intracranial arteries in Japanese patients with ischemic heart disease: Evaluation by brain magnetic resonance angiography. Stroke 27: 393-397.
25. Versari D, Herrmann J, Gössl M, Mannheim D, Sattler K, Meyer FB, Lerman LO, Lerman A. 2006. Dysregulation of the ubiquitin-proteasome system in human carotid atherosclerosis. Arterioscler Thromb Vasc Biol 26: 2132-2139.
26. Watanabe M, Kimura K, Iguchi Y, Urabe T, Shibazaki K, Urabe T, Hattori N. 2010. Peripheral arterial atherosclerosis in patients with extracranial, not intracranial, arterial stenosis. Intern Med 49: 1515-1519.
27. Willis MS, Townley-Tilson WH, Kang EY, Homeister JW, Patterson C. 2010. Sent to destroy: The ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease. Circ Res 106: 463-478.
28. Yeh ET. 2002. Ubiquitin, proteasome, and restenosis: A brave new world for cardiovascular research. Circulation 105: 408-410.